Clinical Trials Arena on MSN
Maze set to target Vertex as kidney disease drug succeeds in Phase II trial
Maze is catching up with Vertex which is also developing a drug with the same target for AMKD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results